This protective signaling is often mediated by HMGB1’s interaction with its receptor, RAGE, leading to the activation of downstream survival pathways such as ERK1/2, which further promotes tumor cell proliferation and chemoresistance [107]. The gene discussed is MAPK3; the disease is neoplasm.